Please use this identifier to cite or link to this item:
|Title:||Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome|
|Authors:||Izar, Maria C. [UNIFESP]|
Fonseca, Henrique A. [UNIFESP]
Pinheiro, Luiz F. [UNIFESP]
Monteiro, Carlos M. [UNIFESP]
Povoa, Rui M. [UNIFESP]
Monteiro, Andrea M.
Figueiredo-Neto, Antonio M.
Gidlund, Magnus A.
Fonseca, Francisco A. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
|Keywords:||Acute coronary syndrome (ACS)|
metabolic syndrome (MetS)
oxidized low-density lipoprotein (oxLDL)
|Publisher:||Sage Publications Ltd|
|Citation:||Diabetes & Vascular Disease Research. London: Sage Publications Ltd, v. 10, n. 1, p. 32-39, 2013.|
|Abstract:||Metabolic syndrome (MetS) is an inflammatory state associated with high coronary disease risk. Inflammation and adaptive immunity modulate atherosclerosis and plaque instability. We examined early changes in anti-oxidized low-density lipoprotein (LDL) (anti-oxLDL) autoantibodies (Abs) in patients with MetS after an acute coronary syndrome (ACS). Patients of both genders (n=116) with MetS were prospectively included after an acute myocardial infarction (MI) or hospitalization due to unstable angina. Anti-oxLDL Abs (IgG class) were assayed at baseline, three and six weeks after ACS. the severity of coronary disease was evaluated by the Gensini score. We observed a decrease in anti-oxLDL Abs titers (p<0.002 vs. baseline), mainly in males (p=0.01), in those under 65 y (p=0.03), and in subjects with Gensini score above median (p=0.04). in conclusion, early decrease in circulating anti-oxLDL Abs is associated with coronary disease severity among subjects with MetS.|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.